U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07144462) titled 'A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases' on Aug. 19.
Brief Summary: The purpose of this study is to determine the safety, tolerability and preliminary efficacy of NEUK203-215 , a healthy donor (HD) allogeneic CD19/BCMA-targeted CAR-NK cell product, in participants with severe, refractory autoimmune diseases.
Study Start Date: Sept. 04
Study Type: INTERVENTIONAL
Condition:
Autoimmune
Intervention:
DRUG: Fludarabine
Specified dose on specified days
DRUG: Cyclophosphamide (C)
Specified dose on specifie...